Compugen Ltd CGEN:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 03/05/21 EST
8.58quote price arrow up+0.28 (+3.44%)
Volume
44,230
Close
8.30quote price arrow up+0.14 (+1.65%)
Volume
2,803,880
52 week range
5.94 - 19.90

...

Loading . . .

KEY STATS

  • Open8.31
  • Day High8.41
  • Day Low7.10
  • Prev Close8.30
  • 52 Week High19.90
  • 52 Week High Date08/26/20
  • 52 Week Low5.94
  • 52 Week Low Date03/18/20
  • Market Cap685.91M
  • Shares Out82.69M
  • 10 Day Average Volume2.27M
  • Dividend-
  • Dividend Yield-
  • Beta2.41
  • 1 Year % Change-11.38

RATIOS/PROFITABILITY

  • EPS (TTM)-0.37
  • P/E (TTM)-22.18
  • Fwd P/E (NTM)-16.66
  • EBITDA (MRQ)-31.496M
  • ROE (MRQ)-37.57%
  • Revenue (MRQ)2.00M
  • Gross Margin (MRQ)97.00%
  • Net Margin (MRQ)-1,484.90%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date05/12/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Compugen Ltd News

QUOTE FINDER

Profile

MORE
Compugen Ltd. is a therapeutic discovery company. The Company focuses on infrastructure to discover drug targets and develop therapeutics. The Company is engaged in the research, development and commercialization of therapeutic and product candidates. The Company's pipeline primarily consists of early and preclinical stage immuno-oncology programs based on drug targets discovered by the Company, primarily immune checkpoint and myeloid protein target candidates. These programs...
Paul Sekhri
Chairman
Anat Cohen-Dayag
President
Ari Krashin
Chief Financial Officer
Zurit Levine Ph.D.
Vice President
Address
Azrieli Center, 26 Harokmim St. Bldg D
Holon
5885849
Israel